Navigation Links
Novel Rules And Regulations For Cardiovascular Catheterization Labs.

A novel set of regulations was established by The Society for Cardiovascular Angiography and Interventions (SCAI).

They were basically for the welfare of the patients// who underwent cardiovascular implantations and other invasive procedures, doctors and other staff members. All the cardiological procedures have become more complex and needs extra care in the sterilization unit.

These rules are mainly to enforce sterilization and prevent infection in the cardiovascular catheterization labs.

The development of a set of rules was made possible with the help of Dr. Charles E. Chambers, (professor of medicine and radiology at Penn State College of Medicine in Hershey, PA) and a jury of skilled doctors.

Nearly 80% of the SCAI members wanted a change from the existing rules. Dr Chamber and his jury set out mainly to the various Centers for Disease Control and Prevention and has gathered the most relevant information and modified it accordingly to the labs needs.

As a result the newly developed set of rules included a number of things such as the type of antibacterial soap to be used. Information regarding the status under which antibiotics must be administered to patients. The protective gloves, clothing, mask adorned by the cardiac catheterization laboratory personnel, level of air movement inside the lab are all detailed.

The rules are easy to understand and follow. It guarantees protection to the patients, staff and on the whole helps in the complete maintenance of the laboratory and prevents infection as they are totally destructive during post interventional catheterizations.

By strictly following these rules the rate of infection can be lowered in the cardiovascular catheterization laboratories.

Page: 1

Related medicine news :

2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... Dental Association meeting in Washington D.C. revolved around the fact that proper dental care, ... The talk stressed the link between periodontal disease (more commonly referred to as gum ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... and convenient way to dispense prescription medications at home, so he invented the ... to monitor and dispense prescription medications. In doing so, it could help to ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... ... 2015 , ... Keeping in mind challenges faced by parents ... consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for children ... and bring advice from parenting experts within their reach. As a part of ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)... Nov. 25, 2015 On Tuesday, November ... bellwether trial against Wright Medical Technology, Inc. for ... Conserve metal-on-metal hip implant device, awarded $11 million ... two week trial and three days of deliberations, ... device was defectively designed and unreasonably dangerous, and ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology: